Natural Product: NPC185634

Natural Product IDNPC185634
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
QOFWRHWADNWKSU-LRXIOGKNSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 10455173
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001534] Quinone and hydroquinone lipids
          • [CHEMONTID:0001546] Vitamin E compounds
            • [CHEMONTID:0002092] Tocotrienols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QOFWRHWADNWKSU-LRXIOGKNSA-N
Standard InCHI InChI=1S/C27H38O4/c1-19(11-7-13-21(3)26(29)30)9-6-10-20(2)12-8-15-27(5)16-14-23-18-24(28)17-22(4)25(23)31-27/h9,12-13,17-18,28H,6-8,10-11,14-16H2,1-5H3,(H,29,30)/b19-9+,20-12+,21-13+/t27-/m1/s1
SMILES C/C(=CCC/C(=C/CC[C@]1(C)CCc2cc(cc(C)c2O1)O)/C)/CC/C=C(C)/C(=O)O

  Calculated Properties

Physi-Chem Properties

MedChem Properties

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

ADMET: Distribution

ADMET: Metabolism

ADMET: Excretion

ADMET: Toxicity

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19087 Garcinia kola Species Clusiaceae Eukaryota Seeds n.a. n.a. PMID[32644811]
NPO19087 Garcinia kola Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19087 Garcinia kola Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19087 Garcinia kola Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19087 Garcinia kola Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT543 Individual protein Pregnane X receptor Homo sapiens Kd = 330.0 nM PMID[32160459]
NPT543 Individual protein Pregnane X receptor Homo sapiens EC50 = 1300.0 nM PMID[32160459]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 57.0 nM PMID[32668380]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 345.0 nM PMID[32668380]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens Activity = 1.4 % PMID[34279935]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 60.0 nM PMID[34279935]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 350.0 nM PMID[34279935]
NPT570 Individual protein Arachidonate 5-lipoxygenase Homo sapiens Activity = 0.4 % PMID[34279935]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1127 Organism Porphyromonas gingivalis Porphyromonas gingivalis MIC = 31300.0 nM PMID[32644811]
NPT1127 Organism Porphyromonas gingivalis Porphyromonas gingivalis MBC = 250.0 uM PMID[32644811]
NPT27 Others Unspecified n.a. Activity = 33.0 % PMID[32160459]
NPT27 Others Unspecified n.a. Activity = 100.0 % PMID[32160459]
NPT1483 Organism Streptococcus sobrinus Streptococcus sobrinus MIC = 31300.0 nM PMID[32644811]
NPT1483 Organism Streptococcus sobrinus Streptococcus sobrinus MBC = 62.5 uM PMID[32644811]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC185634 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7727 Intermediate Similarity NPC479050
0.7705 Intermediate Similarity NPC69539
0.7536 Intermediate Similarity NPC474237
0.75 Intermediate Similarity NPC32152
0.7231 Intermediate Similarity NPC147896
0.6923 Remote Similarity NPC479051
0.6912 Remote Similarity NPC610467
0.6761 Remote Similarity NPC59654
0.6714 Remote Similarity NPC232295
0.6714 Remote Similarity NPC611336
0.6625 Remote Similarity NPC479052
0.662 Remote Similarity NPC204535
0.662 Remote Similarity NPC474131
0.662 Remote Similarity NPC46586
0.662 Remote Similarity NPC609807
0.6528 Remote Similarity NPC271832
0.6528 Remote Similarity NPC600119
0.6528 Remote Similarity NPC601388
0.6351 Remote Similarity NPC610755
0.6267 Remote Similarity NPC474130
0.625 Remote Similarity NPC276962
0.625 Remote Similarity NPC190086
0.6232 Remote Similarity NPC606596
0.6 Remote Similarity NPC196621
0.5844 Remote Similarity NPC474246
0.5797 Remote Similarity NPC45663
0.5769 Remote Similarity NPC474143
0.5753 Remote Similarity NPC483459
0.5753 Remote Similarity NPC483457
0.5753 Remote Similarity NPC483456
0.5753 Remote Similarity NPC483458
0.5714 Remote Similarity NPC95034
0.5714 Remote Similarity NPC142087
0.5714 Remote Similarity NPC603704
0.5443 Remote Similarity NPC475880
0.5195 Remote Similarity NPC483461
0.5063 Remote Similarity NPC609806

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC185634 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5652 Remote Similarity NPD6671 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data